APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Sarcopenia Healthcare

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Sarcopenia Healthcare Market Analysis and Forecast 2026-2032

Report ID 17403397022 January 2026199 pages

Choose your research edition.

Industry ResearchSarcopenia Healthcare Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Sarcopenia Healthcare Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Sarcopenia Healthcare Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sarcopenia Healthcare Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sarcopenia Healthcare Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Sarcopenia Healthcare market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Sarcopenia Healthcare is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Sarcopenia Healthcare is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Sarcopenia Healthcare is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Sarcopenia Healthcare is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Sarcopenia Healthcare include A&Z Pharmaceutical, Abbott Laboratories, Amway, Blackmores, By-health, H&H, Usana, Zhendong Group and Bayer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Sarcopenia Healthcare, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Sarcopenia Healthcare, also provides the revenue of main regions and countries. Of the upcoming market potential for Sarcopenia Healthcare, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sarcopenia Healthcare revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sarcopenia Healthcare market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Sarcopenia Healthcare revenue, projected growth trends, production technology, application and end-user industry.

Sarcopenia Healthcare Segment by Company

A&Z Pharmaceutical

Abbott Laboratories

Amway

Blackmores

By-health

H&H

Usana

Zhendong Group

Bayer

GlaxoSmithKline

Pfizer

Nestlé

Sarcopenia Healthcare Segment by Type

Protein Supplement

Calcium Supplement

Other

Sarcopenia Healthcare Segment by Application

Online Pharmacies

Retail Pharmacies

Sarcopenia Healthcare Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sarcopenia Healthcare market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sarcopenia Healthcare and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sarcopenia Healthcare.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Sarcopenia Healthcare in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Sarcopenia Healthcare company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sarcopenia Healthcare revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sarcopenia Healthcare Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Protein Supplement Major Player Table 3. Calcium Supplement Major Player Table 4. Other Major Player Table 5. Global Sarcopenia Healthcare Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Online Pharmacies Major Player Table 7. Retail Pharmacies Major Player Table 8. Sarcopenia Healthcare Industry Trends Table 9. Sarcopenia Healthcare Industry Drivers Table 10. Sarcopenia Healthcare Industry Opportunities and Challenges Table 11. Sarcopenia Healthcare Industry Restraints Table 12. Global Sarcopenia Healthcare Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Sarcopenia Healthcare Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Sarcopenia Healthcare Market Share by Region (2021-2026) Table 15. Global Sarcopenia Healthcare Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Sarcopenia Healthcare Market Share by Region (2027-2032) Table 17. Global Sarcopenia Healthcare Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Sarcopenia Healthcare Revenue Market Share by Players (2021-2026) Table 19. Global Sarcopenia Healthcare Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Sarcopenia Healthcare Key Players Headquarters & Area Served Table 21. Global Sarcopenia Healthcare Players, Product Type & Application Table 22. Global Sarcopenia Healthcare Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Sarcopenia Healthcare by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Sarcopenia Healthcare Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Sarcopenia Healthcare Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Sarcopenia Healthcare Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Sarcopenia Healthcare Revenue Market Share by Type (2021-2026) Table 29. Global Sarcopenia Healthcare Revenue Market Share by Type (2027-2032) Table 30. Global Sarcopenia Healthcare Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Sarcopenia Healthcare Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Sarcopenia Healthcare Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Sarcopenia Healthcare Revenue Market Share by Application (2021-2026) Table 34. Global Sarcopenia Healthcare Revenue Market Share by Application (2027-2032) Table 35. A&Z Pharmaceutical Company Information Table 36. A&Z Pharmaceutical Business Overview Table 37. A&Z Pharmaceutical Sarcopenia Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. A&Z Pharmaceutical Sarcopenia Healthcare Product Portfolio Table 39. A&Z Pharmaceutical Recent Development Table 40. Abbott Laboratories Company Information Table 41. Abbott Laboratories Business Overview Table 42. Abbott Laboratories Sarcopenia Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Abbott Laboratories Sarcopenia Healthcare Product Portfolio Table 44. Abbott Laboratories Recent Development Table 45. Amway Company Information Table 46. Amway Business Overview Table 47. Amway Sarcopenia Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Amway Sarcopenia Healthcare Product Portfolio Table 49. Amway Recent Development Table 50. Blackmores Company Information Table 51. Blackmores Business Overview Table 52. Blackmores Sarcopenia Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Blackmores Sarcopenia Healthcare Product Portfolio Table 54. Blackmores Recent Development Table 55. By-health Company Information Table 56. By-health Business Overview Table 57. By-health Sarcopenia Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. By-health Sarcopenia Healthcare Product Portfolio Table 59. By-health Recent Development Table 60. H&H Company Information Table 61. H&H Business Overview Table 62. H&H Sarcopenia Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. H&H Sarcopenia Healthcare Product Portfolio Table 64. H&H Recent Development Table 65. Usana Company Information Table 66. Usana Business Overview Table 67. Usana Sarcopenia Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Usana Sarcopenia Healthcare Product Portfolio Table 69. Usana Recent Development Table 70. Zhendong Group Company Information Table 71. Zhendong Group Business Overview Table 72. Zhendong Group Sarcopenia Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Zhendong Group Sarcopenia Healthcare Product Portfolio Table 74. Zhendong Group Recent Development Table 75. Bayer Company Information Table 76. Bayer Business Overview Table 77. Bayer Sarcopenia Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Bayer Sarcopenia Healthcare Product Portfolio Table 79. Bayer Recent Development Table 80. GlaxoSmithKline Company Information Table 81. GlaxoSmithKline Business Overview Table 82. GlaxoSmithKline Sarcopenia Healthcare Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. GlaxoSmithKline Sarcopenia Healthcare Product Portfolio Table 84. GlaxoSmithKline Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Sarcopenia Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Pfizer Sarcopenia Healthcare Product Portfolio Table 89. Pfizer Recent Development Table 90. Nestlé Company Information Table 91. Nestlé Business Overview Table 92. Nestlé Sarcopenia Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Nestlé Sarcopenia Healthcare Product Portfolio Table 94. Nestlé Recent Development Table 95. North America Sarcopenia Healthcare Revenue by Type (2021-2026) & (US$ Million) Table 96. North America Sarcopenia Healthcare Revenue by Type (2027-2032) & (US$ Million) Table 97. North America Sarcopenia Healthcare Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Sarcopenia Healthcare Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Sarcopenia Healthcare Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Sarcopenia Healthcare Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Sarcopenia Healthcare Revenue by Country (US$ Million) & (2027-2032) Table 102. Europe Sarcopenia Healthcare Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe Sarcopenia Healthcare Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe Sarcopenia Healthcare Revenue by Application (2021-2026) & (US$ Million) Table 105. Europe Sarcopenia Healthcare Revenue by Application (2027-2032) & (US$ Million) Table 106. Europe Sarcopenia Healthcare Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Sarcopenia Healthcare Revenue by Country (2021-2026) & (US$ Million) Table 108. Europe Sarcopenia Healthcare Revenue by Country (US$ Million) & (2027-2032) Table 109. China Sarcopenia Healthcare Revenue by Type (2021-2026) & (US$ Million) Table 110. China Sarcopenia Healthcare Revenue by Type (2027-2032) & (US$ Million) Table 111. China Sarcopenia Healthcare Revenue by Application (2021-2026) & (US$ Million) Table 112. China Sarcopenia Healthcare Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Sarcopenia Healthcare Revenue by Type (2021-2026) & (US$ Million) Table 114. Asia Sarcopenia Healthcare Revenue by Type (2027-2032) & (US$ Million) Table 115. Asia Sarcopenia Healthcare Revenue by Application (2021-2026) & (US$ Million) Table 116. Asia Sarcopenia Healthcare Revenue by Application (2027-2032) & (US$ Million) Table 117. Asia Sarcopenia Healthcare Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Sarcopenia Healthcare Revenue by Region (US$ Million) & (2021-2026) Table 119. Asia Sarcopenia Healthcare Revenue by Region (US$ Million) & (2027-2032) Table 120. SAMEA Sarcopenia Healthcare Revenue by Type (2021-2026) & (US$ Million) Table 121. SAMEA Sarcopenia Healthcare Revenue by Type (2027-2032) & (US$ Million) Table 122. SAMEA Sarcopenia Healthcare Revenue by Application (2021-2026) & (US$ Million) Table 123. SAMEA Sarcopenia Healthcare Revenue by Application (2027-2032) & (US$ Million) Table 124. SAMEA Sarcopenia Healthcare Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. SAMEA Sarcopenia Healthcare Revenue by Country (2021-2026) & (US$ Million) Table 126. SAMEA Sarcopenia Healthcare Revenue by Country (US$ Million) & (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Sarcopenia Healthcare Image Figure 2. Global Sarcopenia Healthcare Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sarcopenia Healthcare Market Size Share 2021 VS 2025 VS 2032 Figure 4. Protein Supplement Image Figure 5. Calcium Supplement Image Figure 6. Other Image Figure 7. Global Sarcopenia Healthcare Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Sarcopenia Healthcare Market Size Share 2021 VS 2025 VS 2032 Figure 9. Online Pharmacies Image Figure 10. Retail Pharmacies Image Figure 11. Global Sarcopenia Healthcare Market Size (US$ Million) & (2021-2032) Figure 12. Global Sarcopenia Healthcare Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Sarcopenia Healthcare Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Sarcopenia Healthcare Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Sarcopenia Healthcare Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Sarcopenia Healthcare Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Sarcopenia Healthcare Revenue Market Share by Type (2021-2032) Figure 19. Global Sarcopenia Healthcare Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Sarcopenia Healthcare Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Sarcopenia Healthcare Revenue Market Share by Application (2021-2032) Figure 22. North America Sarcopenia Healthcare Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Sarcopenia Healthcare Revenue Share by Type (2021-2032) Figure 24. North America Sarcopenia Healthcare Revenue Share by Application (2021-2032) Figure 25. North America Sarcopenia Healthcare Revenue Share by Country (2021-2032) Figure 26. United States Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Sarcopenia Healthcare Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Sarcopenia Healthcare Revenue Share by Type (2021-2032) Figure 31. Europe Sarcopenia Healthcare Revenue Share by Application (2021-2032) Figure 32. Europe Sarcopenia Healthcare Revenue Share by Country (2021-2032) Figure 33. Germany Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Sarcopenia Healthcare Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Sarcopenia Healthcare Revenue Share by Type (2021-2032) Figure 43. China Sarcopenia Healthcare Revenue Share by Application (2021-2032) Figure 44. Asia Sarcopenia Healthcare Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Sarcopenia Healthcare Revenue Share by Type (2021-2032) Figure 46. Asia Sarcopenia Healthcare Revenue Share by Application (2021-2032) Figure 47. Asia Sarcopenia Healthcare Revenue Share by Region (2021-2032) Figure 48. Japan Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Sarcopenia Healthcare Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Sarcopenia Healthcare Revenue Share by Type (2021-2032) Figure 56. SAMEA Sarcopenia Healthcare Revenue Share by Application (2021-2032) Figure 57. SAMEA Sarcopenia Healthcare Revenue Share by Country (2021-2032) Figure 58. Brazil Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Sarcopenia Healthcare Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Protein Supplement
  • Calcium Supplement
  • Other
Applications
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • A&Z Pharmaceutical
  • Abbott Laboratories
  • Amway
  • Blackmores
  • By-health
  • H&H
  • Usana
  • Zhendong Group
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Nestlé

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Sarcopenia Healthcare Market by Type
  3. 1.2.1 Global Sarcopenia Healthcare Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Protein Supplement
  5. 1.2.3 Calcium Supplement
  6. 1.2.4 Other
  7. 1.3 Sarcopenia Healthcare Market by Application
  8. 1.3.1 Global Sarcopenia Healthcare Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Online Pharmacies
  10. 1.3.3 Retail Pharmacies
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Sarcopenia Healthcare Market Dynamics
  1. 2.1 Sarcopenia Healthcare Industry Trends
  2. 2.2 Sarcopenia Healthcare Industry Drivers
  3. 2.3 Sarcopenia Healthcare Industry Opportunities and Challenges
  4. 2.4 Sarcopenia Healthcare Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Sarcopenia Healthcare Market Perspective (2021-2032)
  2. 3.2 Global Sarcopenia Healthcare Growth Trends by Region
  3. 3.2.1 Global Sarcopenia Healthcare Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Sarcopenia Healthcare Market Size by Region (2021-2026)
  5. 3.2.3 Global Sarcopenia Healthcare Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Sarcopenia Healthcare Revenue by Players
  2. 4.1.1 Global Sarcopenia Healthcare Revenue by Players (2021-2026)
  3. 4.1.2 Global Sarcopenia Healthcare Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Sarcopenia Healthcare Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Sarcopenia Healthcare Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Sarcopenia Healthcare Key Players Headquarters & Area Served
  7. 4.4 Global Sarcopenia Healthcare Players, Product Type & Application
  8. 4.5 Global Sarcopenia Healthcare Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Sarcopenia Healthcare Market CR5 and HHI
  11. 4.6.3 2025 Sarcopenia Healthcare Tier 1, Tier 2, and Tier 3
5 Sarcopenia Healthcare Market Size by Type
  1. 5.1 Global Sarcopenia Healthcare Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Sarcopenia Healthcare Revenue by Type (2021-2032)
  3. 5.3 Global Sarcopenia Healthcare Revenue Market Share by Type (2021-2032)
6 Sarcopenia Healthcare Market Size by Application
  1. 6.1 Global Sarcopenia Healthcare Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Sarcopenia Healthcare Revenue by Application (2021-2032)
  3. 6.3 Global Sarcopenia Healthcare Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 A&Z Pharmaceutical
  2. 7.1.1 A&Z Pharmaceutical Company Information
  3. 7.1.2 A&Z Pharmaceutical Business Overview
  4. 7.1.3 A&Z Pharmaceutical Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  5. 7.1.4 A&Z Pharmaceutical Sarcopenia Healthcare Product Portfolio
  6. 7.1.5 A&Z Pharmaceutical Recent Developments
  7. 7.2 Abbott Laboratories
  8. 7.2.1 Abbott Laboratories Company Information
  9. 7.2.2 Abbott Laboratories Business Overview
  10. 7.2.3 Abbott Laboratories Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Abbott Laboratories Sarcopenia Healthcare Product Portfolio
  12. 7.2.5 Abbott Laboratories Recent Developments
  13. 7.3 Amway
  14. 7.3.1 Amway Company Information
  15. 7.3.2 Amway Business Overview
  16. 7.3.3 Amway Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Amway Sarcopenia Healthcare Product Portfolio
  18. 7.3.5 Amway Recent Developments
  19. 7.4 Blackmores
  20. 7.4.1 Blackmores Company Information
  21. 7.4.2 Blackmores Business Overview
  22. 7.4.3 Blackmores Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Blackmores Sarcopenia Healthcare Product Portfolio
  24. 7.4.5 Blackmores Recent Developments
  25. 7.5 By-health
  26. 7.5.1 By-health Company Information
  27. 7.5.2 By-health Business Overview
  28. 7.5.3 By-health Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  29. 7.5.4 By-health Sarcopenia Healthcare Product Portfolio
  30. 7.5.5 By-health Recent Developments
  31. 7.6 H&H
  32. 7.6.1 H&H Company Information
  33. 7.6.2 H&H Business Overview
  34. 7.6.3 H&H Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  35. 7.6.4 H&H Sarcopenia Healthcare Product Portfolio
  36. 7.6.5 H&H Recent Developments
  37. 7.7 Usana
  38. 7.7.1 Usana Company Information
  39. 7.7.2 Usana Business Overview
  40. 7.7.3 Usana Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Usana Sarcopenia Healthcare Product Portfolio
  42. 7.7.5 Usana Recent Developments
  43. 7.8 Zhendong Group
  44. 7.8.1 Zhendong Group Company Information
  45. 7.8.2 Zhendong Group Business Overview
  46. 7.8.3 Zhendong Group Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Zhendong Group Sarcopenia Healthcare Product Portfolio
  48. 7.8.5 Zhendong Group Recent Developments
  49. 7.9 Bayer
  50. 7.9.1 Bayer Company Information
  51. 7.9.2 Bayer Business Overview
  52. 7.9.3 Bayer Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Bayer Sarcopenia Healthcare Product Portfolio
  54. 7.9.5 Bayer Recent Developments
  55. 7.10 GlaxoSmithKline
  56. 7.10.1 GlaxoSmithKline Company Information
  57. 7.10.2 GlaxoSmithKline Business Overview
  58. 7.10.3 GlaxoSmithKline Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  59. 7.10.4 GlaxoSmithKline Sarcopenia Healthcare Product Portfolio
  60. 7.10.5 GlaxoSmithKline Recent Developments
  61. 7.11 Pfizer
  62. 7.11.1 Pfizer Company Information
  63. 7.11.2 Pfizer Business Overview
  64. 7.11.3 Pfizer Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Pfizer Sarcopenia Healthcare Product Portfolio
  66. 7.11.5 Pfizer Recent Developments
  67. 7.12 Nestlé
  68. 7.12.1 Nestlé Company Information
  69. 7.12.2 Nestlé Business Overview
  70. 7.12.3 Nestlé Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Nestlé Sarcopenia Healthcare Product Portfolio
  72. 7.12.5 Nestlé Recent Developments
8 North America
  1. 8.1 North America Sarcopenia Healthcare Revenue (2021-2032)
  2. 8.2 North America Sarcopenia Healthcare Revenue by Type (2021-2032)
  3. 8.2.1 North America Sarcopenia Healthcare Revenue by Type (2021-2026)
  4. 8.2.2 North America Sarcopenia Healthcare Revenue by Type (2027-2032)
  5. 8.3 North America Sarcopenia Healthcare Revenue Share by Type (2021-2032)
  6. 8.4 North America Sarcopenia Healthcare Revenue by Application (2021-2032)
  7. 8.4.1 North America Sarcopenia Healthcare Revenue by Application (2021-2026)
  8. 8.4.2 North America Sarcopenia Healthcare Revenue by Application (2027-2032)
  9. 8.5 North America Sarcopenia Healthcare Revenue Share by Application (2021-2032)
  10. 8.6 North America Sarcopenia Healthcare Revenue by Country
  11. 8.6.1 North America Sarcopenia Healthcare Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Sarcopenia Healthcare Revenue by Country (2021-2026)
  13. 8.6.3 North America Sarcopenia Healthcare Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Sarcopenia Healthcare Revenue (2021-2032)
  2. 9.2 Europe Sarcopenia Healthcare Revenue by Type (2021-2032)
  3. 9.2.1 Europe Sarcopenia Healthcare Revenue by Type (2021-2026)
  4. 9.2.2 Europe Sarcopenia Healthcare Revenue by Type (2027-2032)
  5. 9.3 Europe Sarcopenia Healthcare Revenue Share by Type (2021-2032)
  6. 9.4 Europe Sarcopenia Healthcare Revenue by Application (2021-2032)
  7. 9.4.1 Europe Sarcopenia Healthcare Revenue by Application (2021-2026)
  8. 9.4.2 Europe Sarcopenia Healthcare Revenue by Application (2027-2032)
  9. 9.5 Europe Sarcopenia Healthcare Revenue Share by Application (2021-2032)
  10. 9.6 Europe Sarcopenia Healthcare Revenue by Country
  11. 9.6.1 Europe Sarcopenia Healthcare Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Sarcopenia Healthcare Revenue by Country (2021-2026)
  13. 9.6.3 Europe Sarcopenia Healthcare Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Sarcopenia Healthcare Revenue (2021-2032)
  2. 10.2 China Sarcopenia Healthcare Revenue by Type (2021-2032)
  3. 10.2.1 China Sarcopenia Healthcare Revenue by Type (2021-2026)
  4. 10.2.2 China Sarcopenia Healthcare Revenue by Type (2027-2032)
  5. 10.3 China Sarcopenia Healthcare Revenue Share by Type (2021-2032)
  6. 10.4 China Sarcopenia Healthcare Revenue by Application (2021-2032)
  7. 10.4.1 China Sarcopenia Healthcare Revenue by Application (2021-2026)
  8. 10.4.2 China Sarcopenia Healthcare Revenue by Application (2027-2032)
  9. 10.5 China Sarcopenia Healthcare Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Sarcopenia Healthcare Revenue (2021-2032)
  2. 11.2 Asia Sarcopenia Healthcare Revenue by Type (2021-2032)
  3. 11.2.1 Asia Sarcopenia Healthcare Revenue by Type (2021-2026)
  4. 11.2.2 Asia Sarcopenia Healthcare Revenue by Type (2027-2032)
  5. 11.3 Asia Sarcopenia Healthcare Revenue Share by Type (2021-2032)
  6. 11.4 Asia Sarcopenia Healthcare Revenue by Application (2021-2032)
  7. 11.4.1 Asia Sarcopenia Healthcare Revenue by Application (2021-2026)
  8. 11.4.2 Asia Sarcopenia Healthcare Revenue by Application (2027-2032)
  9. 11.5 Asia Sarcopenia Healthcare Revenue Share by Application (2021-2032)
  10. 11.6 Asia Sarcopenia Healthcare Revenue by Country
  11. 11.6.1 Asia Sarcopenia Healthcare Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Sarcopenia Healthcare Revenue by Country (2021-2026)
  13. 11.6.3 Asia Sarcopenia Healthcare Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Sarcopenia Healthcare Revenue (2021-2032)
  2. 12.2 SAMEA Sarcopenia Healthcare Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Sarcopenia Healthcare Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Sarcopenia Healthcare Revenue by Type (2027-2032)
  5. 12.3 SAMEA Sarcopenia Healthcare Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Sarcopenia Healthcare Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Sarcopenia Healthcare Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Sarcopenia Healthcare Revenue by Application (2027-2032)
  9. 12.5 SAMEA Sarcopenia Healthcare Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Sarcopenia Healthcare Revenue by Country
  11. 12.6.1 SAMEA Sarcopenia Healthcare Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Sarcopenia Healthcare Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Sarcopenia Healthcare Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst